Back
Bicara Therapeutics Vs. Pro-Dex Industry Stock Comparison
Buy
60
BCAX
Bicara Therapeutics
Last Price:
$14.55
Seasonality Move:
--
Buy
75
PDEX
Pro-Dex
Last Price:
$65.05
Seasonality Move:
6.94%
Buy
60
Bicara Therapeutics (BCAX)
is a Buy
Is Bicara Therapeutics a Buy, Sell or Hold?
-
The current Bicara Therapeutics [BCAX] share price is $15.63. The Score for BCAX is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
-
BCAX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BCAX Stock Price Chart
What is Bicara Therapeutics's stock price today?
-
The Bicara Therapeutics share price today is $15.63Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BCAX is experiencing buying pressure, which is a positive indicator for future bullish movement.
PDEX Stock Price Chart
BCAX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.36 | Buy |
Relative Strength Index (14 RSI): | 68.06 | Buy |
Chaikin Money Flow: | 220876 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (10.75 - 13.97) | Buy |
Bollinger Bands (100): | (11.47 - 17.39) | Buy |
PDEX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.71 | Buy |
Relative Strength Index (14 RSI): | 68.75 | Buy |
Chaikin Money Flow: | -1301 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (49.61 - 61.59) | Buy |
Bollinger Bands (100): | (38.1 - 54.94) | Buy |
BCAX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 13.05 | Buy |
20-day SMA: | 12.14 | Buy |
50-day SMA: | 12.87 | Buy |
200-day SMA: | 0 | Buy |
8-day EMA: | 13.51 | Buy |
20-day EMA: | 12.68 | Buy |
50-day EMA: | 12.95 | Buy |
200-day EMA: | 11.44 | Buy |
PDEX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 62.14 | Buy |
20-day SMA: | 57.16 | Buy |
50-day SMA: | 47.02 | Buy |
200-day SMA: | 36.73 | Buy |
8-day EMA: | 62.26 | Buy |
20-day EMA: | 57.88 | Buy |
50-day EMA: | 51.16 | Buy |
200-day EMA: | 39.18 | Buy |
Bicara Therapeutics Earnings Growth & BCAX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.02 per share, an increase this year of $1.00 per share, and a decrease next year of $0.52 per share.
Pro-Dex Earnings Growth & PDEX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.21 per share, an increase next quarter of $0.03 per share, an increase this year of $1.80 per share, and an increase next year of $0.08 per share.
Bicara Therapeutics Technical Analysis
Apr 10 | Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
10 | 11 | 14 | 15 | 16 | 17 | 21 | 22 | 23 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Pro-Dex Technical Analysis
Apr 10 | Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
10 | 11 | 14 | 15 | 16 | 17 | 21 | 22 | 23 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |